CHARLES & COLVARD REPORTS FIRST QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET
RESEARCH TRIANGLE PARK, N.C., Nov. 9, 2023 /PRNewswire/ -- Charles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, reported financial results for the first quarter ended September 30, 2023 ("First Quarter Fiscal 2024").
Management Commentary
"While we experienced continued softness in the first quarter, we remain optimistic that our strategic initiatives will help us to overcome weakened consumer spending amidst a challenging economy. Despite industry challenges, we believe we have the product portfolio to meet and exceed customer demands during the upcoming holiday season. We remain focused on reaching broader audiences and capturing greater market share as our investments in technology begin to drive revenue," said Don O'Connell, President and CEO of the Company.
"We are excited and encouraged by the growth opportunities of our shoppable streaming initiative, which we believe will have an important impact on our market positioning and brand awareness. Our in-house technology enables us to reach a wider audience and engage with our customers in innovative ways. We believe there is potential for future revenue growth as we leverage this medium to educate consumers and showcase our Forever OneTM moissanite and Caydia® lab grown diamond product brands in authentic and relatable ways. Additionally, our ability to repurpose long-form content on different channels allows us to maximize the reach and affordability of our marketing strategies," concluded O'Connell.
Recent Corporate Highlights
- Expanded assortment of new Forever OneTM moissanite and Caydia® lab grown diamond fine jewelry styles on charlesandcolvard.com across all categories, including bridal and anniversary styles in both moissanite and lab grown diamond; Couture Collection in lab grown diamond; Made in Color collection in lab grown diamond; fashion jewelry assortment in both moissanite and lab grown diamond; and men's fine jewelry in lab grown diamond;
- Expanded new Forever One™ moissanite styles in Helzberg Diamonds brick-and-mortar stores and helzberg.com;
- Introduced Caydia® lab grown diamond men's fine jewelry styles in select Helzberg Diamond brick-and-mortar stores and helzberg.com;
- Featured in The Scout Guide of Raleigh, Durham, & Chapel Hill showcasing the Company's Signature Showroom; and
- Appeared in thirty brand and product placements and features, including notable outlets such as Today, Glamour, Brides, The Knot, and Bridal Guide.
Financial Summary for First Quarter Fiscal 2024
(Quarter Ended September 30, 2023 Compared to Quarter Ended September 30, 2022)
- Net sales of $5.0 million for the quarter, a decrease of 33% from $7.4 million in the year-ago quarter.
- In the Online Channels segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, charlesandcolvarddirect.com, third-party online marketplaces, drop-ship retail and other pure-play e-commerce outlets, net sales of $3.9 million, a decrease of 19% from the year-ago quarter, representing 79% of total net sales for the quarter, compared to $4.9 million, or 66% of total net sales in the year-ago quarter.
- In the Traditional segment, which consists of wholesale and brick-and-mortar customers, net sales of $1.0 million, a decrease of 59% from the year-ago quarter, representing 21% of total net sales for the quarter, compared to $2.5 million, or 34% of total net sales, in the year-ago quarter.
- Finished jewelry net sales of $4.3 million, a decrease of 22% for the quarter, compared to $5.5 million in the year-ago quarter.
- Loose jewel net sales decreased 64% to $0.7 million for the quarter, compared to $1.8 million in the year-ago quarter.
- Gross profit was $1.9 million, or a gross margin of 39% for the quarter, compared to gross profit of $3.3 million, or gross margin of 45% in the year-ago quarter.
- Operating expenses increased 1% to $4.6 million for the quarter, compared to $4.5 million in the year-ago quarter.
- Net loss was $2.5 million, or $0.08 loss per diluted share for the quarter, compared to net loss of $0.9 million, or $0.03 loss per diluted share, in the year-ago quarter.
- Weighted average diluted shares outstanding were 30.4 million for the quarter, consistent with the year-ago quarter.
Financial Position
Cash, cash equivalents and restricted cash totaled $12.7 million as of September 30, 2023, compared to $15.6 million as of June 30, 2023, representing a decrease of $2.9 million. Total inventory increased to $27.3 million as of September 30, 2023, up from $26.8 million as of June 30, 2023, but down from $36.6 million as of September 30, 2022. The Company had no debt outstanding as of September 30, 2023.
Investor Conference Call
Charles & Colvard will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended September 30, 2023 at 4:30 p.m. ET on Thursday, November 9, 2023.
Live Call-In Information: Interested parties can access the conference call by dialing (844) 875-6912 (U.S. toll-free) or (412) 317-6708 (international) and asking to be joined into the Charles & Colvard call.
Live Webcast Information: Interested parties can access the conference call and accompanying presentation slides via a live webcast, which is available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events or https://www.webcaster4.com/Webcast/Page/346/49381.
A replay of this conference call will be available until November 16, 2023 at (877) 344-7529 (U.S. toll-free) or (412) 317-0088 (international). The replay conference code is 9938382. A webcast replay will be available in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events.
About Charles & Colvard, Ltd.
Charles & Colvard, Ltd. (Nasdaq: CTHR) believes that fine jewelry should be as ethical as it is exquisite. Charles & Colvard is the original creator of lab grown moissanite (a rare gemstone formed from silicon carbide). The Company brings revolutionary gems and fine jewelry to market by using exclusively Made, not MinedTM above ground gemstones and a dedication to 100% recycled precious metals. Their Forever One™ moissanite and Caydia® lab grown diamond brands provide exceptional quality, incredible value and a conscious approach to bridal, high fashion, and everyday jewelry. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit www.charlesandcolvard.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as "may," "will," "should," "could," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "continue," and similar words, although some forward-looking statements are expressed differently.
All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management's current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, (1) our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; (2) our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives; (3) we face intense competition in the worldwide gemstone and jewelry industry; (4) we have historically been dependent on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed; (5) constantly evolving privacy regulatory regimes are creating new legal compliance challenges; (6) our information technology, or IT, infrastructure, and our network has been and may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events; (7) we are subject to certain risks due to our international operations, distribution channels and vendors; (8) our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis; (9) we are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products; (10) we may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation; (11) the effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain; (12) seasonality of our business may adversely affect our net sales and operating income; (13) our operations could be disrupted by natural disasters; (14) sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control; (15) our current customers may potentially perceive us as a competitor in the finished jewelry business; (16) if the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected; (17) governmental regulation and oversight might adversely impact our operations; (18) the execution of our business plans could significantly impact our liquidity; (19) we are subject to arbitration, litigation and demands, which could result in significant liability and costs, and impact our resources and reputation; (20) the financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results; (21) negative or inaccurate information on social media could adversely impact our brand and reputation; (22) we rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business; (23) we may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business; (24) environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations; (25) if we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer; (26) our failure to maintain compliance with The Nasdaq Stock Market's continued listing requirements could result in the delisting of our common stock; (27) some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; and (28) we cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term stockholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance, in addition to the other risks and uncertainties described in more detail in our filings with the U.S. Securities and Exchange Commission (the "SEC"), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2023 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.
- Financial Tables Follow –
CHARLES & COLVARD, LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) | ||||||||
Three Months Ended September 30, | ||||||||
2023 | 2022 | |||||||
Net sales | $ | 4,953,023 | $ | 7,374,083 | ||||
Cost of goods sold | 3,008,507 | 4,086,010 | ||||||
Gross profit | 1,944,516 | 3,288,073 | ||||||
Operating expenses: Sales and marketing | 2,721,965 | 3,107,946 | ||||||
General and administrative | 1,854,268 | 1,413,476 | ||||||
Total costs and expenses | 4,576,233 | 4,521,422 | ||||||
Loss from operations | (2,631,717) | (1,233,349) | ||||||
Other income: | ||||||||
Interest income | 92,260 | 40,201 | ||||||
Total other income | 92,260 | 40,201 | ||||||
Loss before income taxes | (2,539,457) | (1,193,148) | ||||||
Income tax benefit | - | (302,956) | ||||||
Net loss | $ | (2,539,457) | $ | (890,192) | ||||
Net loss per common share: | ||||||||
Basic | $ | (0.08) | $ | (0.03) | ||||
Diluted | $ | (0.08) | $ | (0.03) | ||||
Weighted average number of shares used in computing net loss per | ||||||||
Basic | 30,444,954 | 30,433,195 | ||||||
Diluted | 30,444,954 | 30,433,195 | ||||||
CHARLES & COLVARD, LTD. CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||||||
September 30, 2023 (unaudited) | June 30, 2023 | ||||||||||||
ASSETS | |||||||||||||
Current assets: | |||||||||||||
Cash and cash equivalents | $ 7,592,698 | $ 10,446,532 | |||||||||||
Restricted cash | 5,079,322 | 5,122,379 | |||||||||||
Accounts receivable, net | 442,693 | 380,085 | |||||||||||
Inventory, net | 8,263,043 | 7,476,046 | |||||||||||
Note receivable | 250,000 | 250,000 | |||||||||||
Prepaid expenses and other assets | 969,440 | 901,354 | |||||||||||
Total current assets | 22,597,196 | 24,576,396 | |||||||||||
Long-term assets: | |||||||||||||
Inventory, net | 19,066,682 | 19,277,530 | |||||||||||
Property and equipment, net | 2,534,713 | 2,491,569 | |||||||||||
Intangible assets, net | 315,776 | 305,703 | |||||||||||
Operating lease right-of-use assets | 2,028,736 | 2,183,232 | |||||||||||
Other assets | 49,658 | 49,658 | |||||||||||
Total long-term assets | 23,995,565 | 24,307,692 | |||||||||||
TOTAL ASSETS | $ 46,592,761 | $ 48,884,088 | |||||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||
Current liabilities: | |||||||||||||
Accounts payable | $ 5,652,218 | $ 4,786,155 | |||||||||||
Operating lease liabilities, current portion | 886,117 | 880,126 | |||||||||||
Accrued expenses and other liabilities | 925,385 | 1,395,479 | |||||||||||
Total current liabilities | 7,463,720 | 7,061,760 | |||||||||||
Long-term liabilities: | |||||||||||||
Noncurrent operating lease liabilities | 1,842,468 | 2,047,742 | |||||||||||
Total long-term liabilities | 1,842,468 | 2,047,742 | |||||||||||
Total liabilities | 9,306,188 | 9,109,502 | |||||||||||
Commitments and contingencies | |||||||||||||
Shareholders' equity: | |||||||||||||
Common stock, no par value; 50,000,000 shares | 57,242,211 | 57,242,211 | |||||||||||
Additional paid-in capital | 26,257,363 | 26,205,919 | |||||||||||
Treasury stock, at cost, 388,403 shares at both September | (489,979) | (489,979) | |||||||||||
Accumulated deficit | (45,723,022) | (43,183,565) | |||||||||||
Total shareholders' equity | 37,286,573 | 39,774,586 | |||||||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $ 46,592,761 | $ 48,884,088 | |||||||||||
CHARLES & COLVARD, LTD. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) | |||||||||||||||
Three Months Ended September | |||||||||||||||
2023 | 2022 | ||||||||||||||
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||||||||
Net loss | $ | (2,539,457) | $ | (890,192) | |||||||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||||||
Depreciation and amortization | 178,291 | 137,711 | |||||||||||||
Stock-based compensation | 51,444 | 96,232 | |||||||||||||
Provision for uncollectible accounts | 79,000 | - | |||||||||||||
Recovery of sales returns | (81,000) | (36,000) | |||||||||||||
Inventory write-downs | - | 119,000 | |||||||||||||
Provision for accounts receivable discounts | 9,996 | 3,250 | |||||||||||||
Deferred income taxes | - | (302,956) | |||||||||||||
Changes in operating assets and liabilities: | |||||||||||||||
Accounts receivable | (70,604) | 695,165 | |||||||||||||
Inventory | (576,149) | (3,174,668) | |||||||||||||
Prepaid expenses and other assets, net | 86,410 | (36,616) | |||||||||||||
Accounts payable | 866,063 | 316,819 | |||||||||||||
Accrued expenses and other liabilities | (669,377) | (598,883) | |||||||||||||
Net cash used in operating activities | (2,665,383) | (3,671,138) | |||||||||||||
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||||||||
Purchases of property and equipment | (217,052) | (430,400) | |||||||||||||
Payments for intangible assets | (14,456) | (2,214) | |||||||||||||
Net cash used in investing activities | (231,508) | (432,614) | |||||||||||||
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||||||||
Repurchases of common stock | - | (451,815) | |||||||||||||
Net cash used in financing activities | - | (451,815) | |||||||||||||
NET DECREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | (2,896,891) | (4,555,567) | |||||||||||||
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, BEGINNING OF | 15,568,911 | 21,179,340 | |||||||||||||
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, END OF PERIOD | $ | 12,672,020 | $ | 16,623,773 | |||||||||||
Supplemental disclosure of cash flow information: | |||||||||||||||
Cash paid during the period for income taxes | $ | - | $ | 5,900 | |||||||||||
Reconciliation to Condensed Consolidated Balance Sheets: | September 30, 2023 | June 30, 2023 | |||||||||||||
Cash and cash equivalents | $ | 7,592,698 | $ | 10,446,532 | |||||||||||
Restricted cash | 5,079,322 | 5,122,379 | |||||||||||||
CASH, CASH EQUIVALENTS AND RESTRICTED CASH | $ | 12,672,020 | $ | 15,568,911 | |||||||||||
View original content to download multimedia:https://www.prnewswire.com/news-releases/charles--colvard-reports-first-quarter-fiscal-year-2024-financial-results-301983857.html
SOURCE Charles & Colvard, Ltd.
